JO1768B1 - Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic - Google Patents

Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic

Info

Publication number
JO1768B1
JO1768B1 JO19931768A JOP19931768A JO1768B1 JO 1768 B1 JO1768 B1 JO 1768B1 JO 19931768 A JO19931768 A JO 19931768A JO P19931768 A JOP19931768 A JO P19931768A JO 1768 B1 JO1768 B1 JO 1768B1
Authority
JO
Jordan
Prior art keywords
substance
acid degradable
acid
inhibiting effect
synergistic combination
Prior art date
Application number
JO19931768A
Other languages
Arabic (ar)
Inventor
تورستين إيك أرني
اريك سجوستراند سفين
Original Assignee
تورستين إيك أرني
اريك سجوستراند سفين
اكتيبولاغيت استرا
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by تورستين إيك أرني, اريك سجوستراند سفين, اكتيبولاغيت استرا filed Critical تورستين إيك أرني
Priority to JO19931768A priority Critical patent/JO1768B1/en
Application granted granted Critical
Publication of JO1768B1 publication Critical patent/JO1768B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention consists of a combination of a substance that increases the intragastric pH and an acid degradable antibacterial compound. By this combined product regimen it will be possible to obtain maximal local antibacterial effect of acid degradable antibiotics as well as enhanced bioavailability of the active antibiotic, thus resulting in higher amounts of the active compound in the gastric mucosa due to secretion of weak bases. Both pharmacological effects contribute to drastically increased antimicrobial capacity of acid degradable antibiotics to be used against local infections in the gastrointestinal tract causing gastritis and/or peptic ulcer. The invention also selects to the use of said combination and a process for the preparation thereof.
JO19931768A 1993-10-24 1993-10-24 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic JO1768B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO19931768A JO1768B1 (en) 1993-10-24 1993-10-24 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO19931768A JO1768B1 (en) 1993-10-24 1993-10-24 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic

Publications (1)

Publication Number Publication Date
JO1768B1 true JO1768B1 (en) 1994-05-15

Family

ID=48092610

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19931768A JO1768B1 (en) 1993-10-24 1993-10-24 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic

Country Status (1)

Country Link
JO (1) JO1768B1 (en)

Similar Documents

Publication Publication Date Title
MY121189A (en) Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
WO2000062783A3 (en) Ketolide antibacterials
AU2002222296A1 (en) Macrolide antibiotics
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
CA2359708A1 (en) Ketolide antibiotics
CA2340052A1 (en) Pharmaceutical compositions containing lipase inhibitors and chitosan
CA2034569A1 (en) Oral pharmaceutical forms of pimobendan
WO2000026224A3 (en) Novel macrolide antibiotics
IT1262993B (en) RITNITINE AND ANTIBIOTIC BISMUTO CITRATE COMPLEX, COMPOSITION CONTAINING IT AND RELATED METHOD OF PRODUCTION AND USE
CA2338736A1 (en) Method and composition for enhancing milk production
WO2000011000A3 (en) New compounds
IE843095L (en) Benzimidazoles
MY140994A (en) Delayed-release preparations of quinolone antibiotics and process for their preparation
WO2002015842A3 (en) Process for preparation of anhydrous azithromycin
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
TR199800421A2 (en) Bismuth salts of moenomycin group antibiotics.
JO1768B1 (en) Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
CA2388076A1 (en) Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
IE780631L (en) Azabicycloheptenes
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
WO2001097791A3 (en) Use of c4-c10 acids for preventing gram-negative bacterial infections
WO2000010998A3 (en) Pyridone antibiotic with improved safety profile
ES8402286A1 (en) Beta-lactam antibiotics, process for their preparation and their use as medicines.
MX9202034A (en) COMPOSITION OF DERIVATIVES OF ANTIBIOTICS OF MACROLIDE FOR THE TREATMENT OR PREVENTION OF MASTITIS IN RUMINANTS.
AU8127398A (en) Polyol-amino acid compounds having anti-(helicobacter pylori) activity